These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 170051)

  • 1. [In vivo dissolving of gall-stones: the effect of chenodeoxycholic acid. (author's transl)].
    Fromm H; Eschler A; Töllner D; Canzler H; Schmidt FW
    Dtsch Med Wochenschr; 1975 Aug; 100(32):1619-24. PubMed ID: 170051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to chenodeoxycholic acid (CDCA) treatment in obese patients with gall stones.
    Iser JH; Maton PN; Murphy GM; Dowling RH
    Br Med J; 1978 Jun; 1(6126):1509-12. PubMed ID: 656777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of chenodeoxycholic acid (CDCA) on cholesterol absorption.
    Ponz de Leon M; Carulli N; Loria P; Iori R; Zironi F
    Gastroenterology; 1979 Aug; 77(2):223-30. PubMed ID: 447035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of chenodeoxycholic acid (CDCA) treatment in 125 patients with radiolucent gallstones. Factors influencing efficacy, withdrawal, symptoms and side effects and post-dissolution recurrence.
    Maton PN; Iser JH; Reuben A; Saxton HM; Murphy GM; Dowling RH
    Medicine (Baltimore); 1982 Mar; 61(2):86-97. PubMed ID: 7062856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different effects of chenodeoxycholic acid and ursodeoxycholic acid on serum lipoprotein concentrations in patients with radiolucent gallstones.
    Leiss O; von Bergmann K
    Scand J Gastroenterol; 1982 Aug; 17(5):587-92. PubMed ID: 7178821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of patients with gallstones with chenodeoxycholic acid (author's transl)].
    Leuschner U; Reber E; Erb W
    Dtsch Med Wochenschr; 1977 Feb; 102(5):156-60. PubMed ID: 832601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleation time of gall bladder bile in gall stone patients: influence of bile acid treatment.
    Sahlin S; Ahlberg J; Angelin B; Reihnér E; Einarsson K
    Gut; 1991 Dec; 32(12):1554-7. PubMed ID: 1773966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dissolution of gallstones by chenodeoxycholic acid].
    Brändli HH; Hefti ML; Blum AL
    Schweiz Med Wochenschr; 1977 Dec; 107(48):1770-3. PubMed ID: 337470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of choledocholithiasis with oral chenodeoxycholic acid.
    Sue SO; Taub M; Pearlman BJ; Marks JW; Bonorris GG; Schoenfield LJ
    Surgery; 1981 Jul; 90(1):32-4. PubMed ID: 7017991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of the conservative cholelitholytic therapy using chenodesoxycholic acid (CDC) on cholesterol and triglycerides in the blood of patients with gall stones].
    Caspary WF; Kattermann R
    Z Gastroenterol; 1975 Nov; 13(7):644-7. PubMed ID: 820098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral dissolution therapy for cholelithiasis: mix and match.
    Phillips RS; Barkin JS
    Am J Gastroenterol; 1990 Nov; 85(11):1532-3. PubMed ID: 2239886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined therapy with chenodeoxycholic acid and ursodeoxycholic acid of radiolucent biliary lithiasis].
    Pérez Aguilar F; Breto M; del Val A; Berenguer J
    An Med Interna; 1989 Mar; 6(3):119-24. PubMed ID: 2491184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-cholesterol diet: enhancement of effect of CDCA in patients with gall stones.
    Maudgal DP; Bird R; Blackwood WS; Northfield TC
    Br Med J; 1978 Sep; 2(6141):851-3. PubMed ID: 709092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chenodeoxycholic acid therapy for gallstones: effectiveness, toxicity and influence on bile acid metabolism.
    James O; Cullen J; Bouchier IA
    Q J Med; 1975 Apr; 44(174):349-67. PubMed ID: 1178813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oral chenodeoxycholic acid on bile acid kinetics and biliary lipid composition in women with cholelithiasis.
    Danzinger RC; Hofmann AF; Thistle JL; Schoenfield LJ
    J Clin Invest; 1973 Nov; 52(11):2809-21. PubMed ID: 4583981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and specificity of chenodeoxycholic acid therapy for dissolving gallstones.
    Thistle JL; Hofmann AF
    N Engl J Med; 1973 Sep; 289(13):655-9. PubMed ID: 4580472
    [No Abstract]   [Full Text] [Related]  

  • 17. Chenodeoxycholic acid: a review of its pharmacological properties and therapeutic use.
    Iser JH; Sali A
    Drugs; 1981 Feb; 21(2):90-119. PubMed ID: 7009140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucin in gall bladder bile of gall stone patients: influence of treatment with chenodeoxycholic acid and ursodeoxycholic acid.
    Sahlin S; Danielsson A; Angelin B; Reihnér E; Henriksson R; Einarsson K
    Gut; 1988 Nov; 29(11):1506-10. PubMed ID: 3209106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum lipids in cholelithiasis: effect of chenodeoxycholic acid therapy.
    Bell GD; Lewis B; Petrie A; Dowling RH
    Br Med J; 1973 Sep; 3(5879):520-3. PubMed ID: 4741607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gall-stone dissolution treatment using cholelitholytic bile acids: experience with 24 patients.
    van Erpecum KJ; van Berge Henegouwen GP; van der Werf SD
    Neth J Med; 1989 Feb; 34(1-2):3-9. PubMed ID: 2644556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.